Description
Sitagliptin is an oral anti-hyperglycemic medicine that belongs to the class of DPP-4 inhibitors. It is used to manage type II diabetes mellitus in adjunct to lifestyle changes.
Primary Uses
Type II diabetes
Indications
Monotherapy: This medicine is used for treating type 2 diabetes (condition characterized by elevated glucose levels) that is inadequately controlled by metformin, diet and exercise.
Side Effects
The patients administered with this medicine may experience pancreatitis (inflammation of pancreas), allergic reactions, Stevens-Jhonson Syndrome (allergic reaction), Hypoglycemia (low glucose levels), bullous pemphigoid (large fluid-filled blisters), osteoarthritis (weak bones), upper respiratory tract infections, flatulence, swelling, and influenza (flu-like symptoms).
Reviews
There are no reviews yet.